Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 8343 participants.
Also called NCT05439356
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 8,343 participants
- Sponsor
- Registry
-
NCT05439356
-
- Other papers using this trial's data
- Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05439356. Randomized; quadruple masking; primary purpose prevention. Start 2022-08-11 (actual); primary completion 2023-07-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)
- Condition
- Ischemic Stroke
- Condition
- TIA (transient ischemic attack)
- Intervention (Drug)
- Colchicine
- Intervention (Drug)
- Placebo colchicine
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct05439356- Content hash
fb0c7b0b38db1c7bc043cbf49ac1cd5b1f0eca2372126220b7fbd9ce110a1870